A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
480
about 5 years
18+
7 sites in NJ, NY
What this study is about
This trial is testing whether a virtual mind-body program, Integrative Medicine at Home (IM@Home), will improve patients' perceived values, outcomes, and experiences during cancer treatment. It involves people with gynecologic cancer, gynecologic tumors, head and neck cancer, head and neck tumors, melanoma, ovarian cancer, thoracic cancer, or thoracic tumors. Participants will receive enhanced usual care along with the IM@HOME program.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Enhanced usual care
- 2.Receive IM@Home
Participation Burden
What's physically and logistically required of participants.
Some or all participation from home
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Average Fatigue Severity from the Brief Fatigue Inventory (BFI)
Secondary: Effect of treatments on psychological distress as measured by Hospital Anxiety and Depression Scale (HADS), Insomnia severity as measured by Insomnia Severity Index (ISI), Pain as measured by Patient Reported Outcomes Measurement Information System (PROMIS®) Scale v1.2 - Global Health, Symptom intensity as measured by Edmonton Symptom Assessment Scale (ESAS)
Oncology